Enzymatica AB (publ) (STO:ENZY)
1.930
-0.070 (-3.50%)
Oct 31, 2025, 12:18 PM CET
Enzymatica AB Revenue
Enzymatica AB had revenue of 15.01M SEK in the quarter ending September 30, 2025, with 19.43% growth. This brings the company's revenue in the last twelve months to 52.73M, up 19.17% year-over-year. In the year 2024, Enzymatica AB had annual revenue of 45.58M, down -10.47%.
Revenue (ttm)
52.73M
Revenue Growth
+19.17%
P/S Ratio
8.88
Revenue / Employee
2.51M
Employees
21
Market Cap
468.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.58M | -5.33M | -10.47% |
| Dec 31, 2023 | 50.90M | 1.96M | 4.00% |
| Dec 31, 2022 | 48.95M | -8.30M | -14.49% |
| Dec 31, 2021 | 57.24M | -54.00M | -48.54% |
| Dec 31, 2020 | 111.25M | 49.94M | 81.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |